(Press-News.org) Contact information: Heath McCoy
hjmccoy@ucalgary.ca
403-220-5089
University of Calgary
Researcher says extensive use of antibiotics in agriculture creating public health crisis
University of Calgary's Aidan Hollis advocates user fees on non-human antibiotics use
Citing an overabundance in the use of antibiotics by the agriculture and aquaculture industries that poses a threat to public health, economics professor Aidan Hollis has proposed a solution in the form of user fees on the non-human use of antibiotics.
In a newly released paper published in the New England Journal of Medicine, Hollis and co-author Ziana Ahmed state that in the United States 80 per cent of the antibiotics in the country are consumed in agriculture and aquaculture for the purpose of increasing food production.
This flood of antibiotics released into the environment – sprayed on fruit trees and fed to the likes of livestock, poultry and salmon, among other uses – has led bacteria to evolve, Hollis writes. Mounting evidence cited in the journal shows resistant pathogens are emerging in the wake of this veritable flood of antibiotics – resulting in an increase in bacteria that is immune to available treatments.
If the problem is left unchecked, this will create a health crisis on a global scale, Hollis says.
Hollis suggest that the predicament could be greatly alleviated by imposing a user fee on the non-human uses of antibiotics, similar to the way in which logging companies pay stumpage fees and oil companies pay royalties.
"Modern medicine relies on antibiotics to kill off bacterial infections," explains Hollis. "This is incredibly important. Without effective antibiotics, any surgery – even minor ones – will become extremely risky. Cancer therapies, similarly, are dependent on the availability of effective antimicrobials. Ordinary infections will kill otherwise healthy people."
Bacteria that can effectively resist antibiotics will thrive, Hollis adds, reproducing rapidly and spreading in various ways.
"It's not just the food we eat," he says. "Bacteria is spread in the environment; it might wind up on a doorknob. You walk away with the bacteria on you and you share it with the next person you come into contact with. If you become infected with resistant bacteria, antibiotics won't provide any relief."
While the vast majority of antibiotic use has gone towards increasing productivity in agriculture, Hollis asserts that most of these applications are of "low value."
"It's about increasing the efficiency of food so you can reduce the amount of grain you feed the cattle," says Hollis. "It's about giving antibiotics to baby chicks because it reduces the likelihood that they're going to get sick when you cram them together in unsanitary conditions.
"These methods are obviously profitable to the farmers, but that doesn't mean it's generating a huge benefit. In fact, the profitability is usually quite marginal.
"The real value of antibiotics is saving people from dying. Everything else is trivial."
While banning the use of antibiotics in food production is challenging, establishing a user fee makes good sense, according to Hollis.
Such a practice would deter the low-value use of antibiotics, with higher costs encouraging farmers to improve their animal management methods and to adopt better substitutes for the drugs, such as vaccinations.
Hollis also suggests that an international treaty could ideally be imposed. "Resistant bacteria do not respect national borders," he says. He adds that such a treaty might have a fair chance of attaining international compliance, as governments tend to be motivated by revenue collection.
Hollis notes that in the U.S., a move has been made to control the non-human use of antibiotics, with the FDA recently seeking voluntary limits on the use of antibiotics for animal growth promotion on farms.
He asks: "Is the Canadian government going to take any action to control the use of antibiotics for food production purposes? Health Canada is trying to monitor the use of antibiotics, but has virtually no control over use."
INFORMATION:
Researcher says extensive use of antibiotics in agriculture creating public health crisis
University of Calgary's Aidan Hollis advocates user fees on non-human antibiotics use
2013-12-27
ELSE PRESS RELEASES FROM THIS DATE:
Rheumatoid arthritis research shows the potential of large-scale genetic studies for drug discovery
2013-12-27
Rheumatoid arthritis research shows the potential of large-scale genetic studies for drug discovery
The results of the largest international study to date into the genetic basis of rheumatoid arthritis shed light on the biology of the disease and provide evidence that large-scale genetic ...
Special topic: Airworthiness and fatigue
2013-12-27
Special topic: Airworthiness and fatigue
Aviation safety is the theme given to the International Conference on Airworthiness and Fatigue: 7th ICSAELS Series Conference, Beijing, China, held on 25 March, 2013. This event was initiated by the International Center of ...
Molecular markers used for assessment of early sciatic nerve injury
2013-12-27
Molecular markers used for assessment of early sciatic nerve injury
Substance P and calcitonin gene-related peptide are the main neuropeptides in peripheral nerve ganglia, which can anterogradely transmit nociceptive information to the central nervous system. In ...
Genetic discovery points the way to much bigger yields in tomato, other flowering food plants
2013-12-27
Genetic discovery points the way to much bigger yields in tomato, other flowering food plants
Scientists learn how tweaking a 'hybrid vigor' gene generates higher crop yields
Cold Spring Harbor, NY – Every gardener knows the look of a ripe tomato. That bright ...
Building a better malaria vaccine: Mixing the right cocktail
2013-12-27
Building a better malaria vaccine: Mixing the right cocktail
A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26 in PLOS Pathogens suggest how a leading vaccine ...
Gene therapy for human skin disease produces long-term benefits
2013-12-27
Gene therapy for human skin disease produces long-term benefits
Stem cell-based gene therapy holds promise for the treatment of devastating genetic skin diseases, but the long-term clinical outcomes of this approach have been unclear. In a study online December 26th in the ...
The fate of the eels
2013-12-27
The fate of the eels
GEOMAR scientists prove oceanographic influences on eel recruitment
Smoked, fried or boiled - the European eel (Anguilla anguilla) has always been a popular fish in Europe. Even though people have consumed it for millennia, the origin ...
Are concussions related to Alzheimer's disease?
2013-12-27
Are concussions related to Alzheimer's disease?
MINNEAPOLIS – A new study suggests that a history of concussion involving at least a momentary loss of consciousness may be related to the buildup of Alzheimer's-associated plaques in the brain. The research ...
Surgery beats chemotherapy for tongue cancer, U-M study finds
2013-12-27
Surgery beats chemotherapy for tongue cancer, U-M study finds
ANN ARBOR, Mich. — Patients with tongue cancer who started their treatment with a course of chemotherapy fared significantly worse than patients who received surgery first, according ...
Researchers point to digital gains in human recognition
2013-12-27
Researchers point to digital gains in human recognition
Human beings are highly efficient at recognising familiar faces, even from very poor quality images.
New research led by a psychologist at the University of York is using advances in the level of detail ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Researcher says extensive use of antibiotics in agriculture creating public health crisisUniversity of Calgary's Aidan Hollis advocates user fees on non-human antibiotics use